Preclinical profile of cabazitaxel

First-generation taxanes have changed the treatment paradigm for a wide variety of cancers, but innate or acquired resistance frequently limits their use. Cabazitaxel is a novel second-generation taxane developed to overcome such resistance. In vitro, cabazitaxel showed similar antiproliferative act...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrignaud, Patricia, Semiond, Dorothée, Benning, Veronique, Beys, Eric, Bouchard, Hervé, Gupta, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207555/
https://www.ncbi.nlm.nih.gov/pubmed/25378905
http://dx.doi.org/10.2147/DDDT.S64940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207555/
https://www.ncbi.nlm.nih.gov/pubmed/25378905
http://dx.doi.org/10.2147/DDDT.S64940

Ejemplares similares